Exploitation of Patented Inventions
D. Shanker, The Par. 6 Solution of the Doha Public health Declaration and Export under the TRIPs Agreement, in 7 JWIP 2004, 365-400
K.M. Gopakumar, The WTO Deal on Cheap Drugs A Critique, in 7 JWIP 2004, 99-114
N. Gallus, The Mystery of Pharmaceutical Parallel Trade and Developing Countries, in 7 JWIP 2004, 169-184
T. Kongolo, Compulsory License Issues in Africa Arab Countries, in 7 JWIP 2004, 185-200
S. Musungu and E. Noehrenberg, IP and Public Health Will it be Peace or War? in 7 JWIP 2004, 249 ff.
M. Turton-A. Mills, The First Sale Doctrine and Parallel Imports in the US after Jazz Photo, in EIPR 2004, 148-152
Xiang Yu, The Regime of Exhaustion and Parallel Imports in China: A Study Based on the Newly Amended Chinese Law and Related Cases, in EIPR 2004, 105-112
T. Hays, Parallel Importation under EU Law, Thomson, Sweet & Maxwell, 2003 (EU 45)
P. Rey-J.S. Venit, Parallel trade and pharmaceuticals: a policy in search of itself, in 29 Eu. L. R.. 2004, 153-177
Haochen Sun, Reshaping the TRIPs Agreement concerning Public Health Two Critical Issues, in 37 J. of World Trade 2003, 163-196
F.M. ABBOTT, The TRIPs Agreement, Access to Medicines, and the WTO Doha Ministerial Conference, in 5 Journal of World Intellectual Property, 2002, 15 ff.
A. Tawanda Magaisa, Minister of Health and Others v. Treatment Action Campaign and Others, in J. of African L. 2003, 117-125
P. CHAMP-A. ATTARAN, Patent Rights and Local Working under the WTO TRIPs Agreement: An Analysys of the U.S.-Brazil Dispute, in 27 The Yale Journal of International Law, 2002, 365 ff.
D. SHANKER, India, the Pharmaceutical Industry and the Validity of TRIPs, in The Journal of World Intellectual Property, 2002, 315 ff.
D. SHANKER, Brazil, the Pharmaceutical Industry and the WTO, in 5 The Journal of World Intellectual Property 2002, 53 ff.
R. Howse, The Canadian Generic Medicines Panel: A Dangerous Precedent in Dangerous Times, in 3 J. World Intell. Prop., 2002, 493 ff.
M.R. Franzinger, Latent Dangers in a Patent Pool: the European Commissions Approval of the 3G Wireless Technology Licensing Agreements, in 91 California Law Review 2003, 1693-1727
A. van der Merwe, Use of Pharmaceutical Patents: Some Thoughts from South Africa, in IPQ 2004, 198 ff.
D. Matthews, WTO Decision on Implementation of Paragraph 6 of the Doha Declaration on the Trips Agreement and Public Health: A Solution to the Access to Essential Medicines Problem?, 7 JIEL 2004, 73 ff.
F.M. Abbott, The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a Dark Corner at the WTO, in 5 JIEL 2002, 469 ff.;
M. BARRETT, A Fond Farewell to Parallel Imports of Patented Goods: The US and the Rule of International Exahustion, in EIPR 2002, 571 ff.
D. SINDICO, On Parallel Importation, TRIPs and European Court of Justice Decisions, in 5 The Journal of World Intellectual Property, 2002, 505 ff.
C. FINK, Entering the Jungle: the Exhaustion of Intellectual Property Rights and Parallel Imports, in O. LIPPERT, Competitive Strategies for Intellectual Property Protection, Vancouver, BC, The Fraser Institute, 1999, 173 ff. (INT 1117)
D.M. GITTER, International Conflicts Over Patenting Human DNA Sequences in the US and the EU: An Argument for Compulsory Licensing and a Fair-Use Exemption, in 76 N.Y.U. L. Rev. 2001, 1623 ff.
J. AMMAN, Intellectual Property and Parallel Imports, in 26 Legal Issues of European Integration, 1999, 91 ff.
L.-J. Zadra-Symes-J.J. Basista, Using U.S. Intellectual Property Rights to Prevent Parallel Imports, in EIPR 1998, 219-225.
J.A. Tessensohn-S. Yamamoto, The Big Aluminium Wheel Dust Up International Exhaustion of Rights in Japan, in EIPR 1998, 228-238.
V. CHIAPPETTA, The Desiderability of Agreeing to Disagree: the WTO, TRIPS, International IPR Exhaustion and Few Other Things, in 3 Michigan Journal of International Law, 2000, 333 ff.
C.T. Feddersen, Parallel Trade in Pharmaceutical in a Europe of 25: What the Specific Mechanism Achieves and What It Does Not, in EIPR 2003, 545-555
K. INGLIS, The Europe Agreements compared in the light of their pre-accession orientation, in 37 CMLR, 2000, 1173 ff.
A. TOUTOUNGI, Intel v. Via: Holding back the Tide of Compulsory Licensing? in EIPR a02, 548 ff.
P. Rott, The Doha Declaration Good News for Public Health? in IPQ 2003, 284-311
L. Ferreira, Access to Affordable HIV/AIDS Drugs: the Human Rights Obligations of Multinational Pharmaceutical Corporations, in 71 Fordham Law Rev. 2002, 1133-1179
S. VASTANO VAUGHAN, Compulsory Licensing of Pharmaceuticals Under TRIPs: What Standards of Compensation? in 25 Hastings International and Comparative Law Review, 2001, 87 ff.
C. OTERO GARCIA-CASTRILLON, An Approach to the WTO Ministerial Declarations on the TRIPs Agreement and Public Health, in 5 Journal of Int. Ec. Law, 2002, 212 ff.
H.S. HARRIS, Jr., Competition Law and Patent Protection in Japan: A Half Century of Progress, A New Millennium of Challenges, in 16 Columbia Journal of Asian Law, 2002, 71-140.
P.D. Curran, Standard-Setting Organizations: Patents, Price Fixing, and Per Se Legality, in 70 U. Chi. L. Rev. 2003, 983-1010
M. A. Carrier, Unraveling the Patent-Antitrust Paradox, 150 U. Pa. L. Rev., 2002, 761 ff.
J. PITZ, Exhaustion of Industrial Property Rights from the German Perspective, in 4 The Journal of World Trade Law, 2001, 463 ff.